my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
15-03-2011: co.don AG has announced yet another great achievement. An important patent has been granted recently to the Brandenburg enterprise by the American patent office "United States Patent and Trademark Office". The refined method by co.don AG for growing three-dimensional autologous cell transplants (ACT-3D) is now protected on the US market. Application for a patent was filed back in 2001.
"Being awarded the patent gives us a leading position in technology and know-how in North America," says Dr. Andreas Baltrusch, CEO of co.don AG. The US is one of the largest health care markets worldwide. "The patent application," according to Dr. Baltrusch, "has been an important step towards selling co.don AG products abroad in future."
The US-Patent, with the number 7 887 843 B2, protects the method of growing transplants, the base for the co.don chondrosphere® product. These transplants are used for the treatment of damages to the articular cartilage in knee, hip, ankle, elbow and shoulder joints. For this treatment, healthy articular cartilage cells are removed from the patient, then isolated in the laboratory and by adding the patient's own blood serum, cultivated into a three-dimensional cartilage cell transplant within a few weeks. With a minimally invasive intervention, the autologous transplant is then implanted into the damaged articular cartilage, a gentle method for the patient, which often makes the use of prosthesis superfluous later on.
This patent-protected cell cultivation by co.don AG abstains completely from using antibiotics, growing factors and fungistats (antifungal agents). Furthermore, these products are made without any genetic modification and without alien matrix despite its three-dimensionality.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
co.don AG is awarded the US-Patent: Process to produce cell transplants patented successfully
co.don AG has announced yet another great achievement. An important patent has been granted recently to the Brandenburg enterprise by the American patent office "United States Patent and Trademark Office". The refined method by co.don AG for growing three-dimensional autologous cell transpl ... more
co.don AG signs an exclusive distribution agreement for Greece
co.don® AG has signed an exclusive two-year distribution agreement with ARTHROSIS SA, Metamorfosi, near Athens, Greece, - to market co.don chondrosphere® , co.don chondrotransplant® DISC and co.don osteotransplant® DENT in Greece. ARTHROSIS SA is an established distribution company which h ... more
The ability to heal damaged tissue and organs naturally decreases with age. Regeneration of skin, muscle, connective, cartilage and bone tissue in human beings, for example, is reduced by a progressive specialization of the tissue cells. A remedial innovative technology exists which allow ... more
PBL awarded two US patents on RNAi
Plant Bioscience Limited (PBL) announced that the United States Patent and Trademark Office (USPTO) has issued out US Patent No. 8,258,285 with fundamental claims directed to compositions to effect gene silencing and US Patent No. 8,263,569 with fundamental claims directed to methods of ind ... more
US Patent Granted for Verona Pharma’s RPL554
Verona Pharma plc announced that the United States Patent and Trademark Office has granted a new patent for the Company’s lead drug candidate, RPL554. The patent is the fourth patent issued for RPL554 and related compounds in the US.RPL554, Verona Pharma's lead drug candidate, is a dual pho ... more
New Patents Issued to Diffusion Pharmaceuticals
Diffusion Pharmaceuticals LLC announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled “Bipolar Trans Carotenoids Salts and Their Uses” and “Trans Carotenoids, Their Synthesis and Uses,” respectively. These patents include compound, com ... more
U.S. Patent & Trademark Office (USPTO)
The United States Patent and Trademark Office (USPTO) is the Federal agency for granting U.S. patents and registering trademarks. In doing this, the USPTO fulfills the mandate of Article I, Section 8, Clause 8, of the Constitution that the Executive branch "promote the progress of science a ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
